|
21 Sep 2025 |
Jyothy Labs
|
Consensus Share Price Target
|
322.50 |
399.38 |
- |
23.84 |
buy
|
|
|
|
|
26 May 2022
|
Jyothy Labs
|
Yes Securities
|
322.50
|
181.00
|
152.75
(111.13%)
|
Target met |
Buy
|
|
|
|
|
25 May 2022
|
Jyothy Labs
|
Sharekhan
|
322.50
|
175.00
|
149.00
(116.44%)
|
Target met |
Buy
|
|
|
|
|
25 May 2022
|
Jyothy Labs
|
ICICI Direct
|
322.50
|
145.00
|
153.80
(109.69%)
|
Target met |
Hold
|
|
|
|
|
28 Jan 2022
|
Jyothy Labs
|
Geojit BNP Paribas
|
322.50
|
165.00
|
139.20
(131.68%)
|
Target met |
Accumulate
|
|
|
EBITDA margin declined by 540bps YoY to 11.3% (Vs.11.4% in Q2FY22 & 12% in Q1FY22) due to 710bps reduction in Gross margin on account of sharp increase in input prices. Some input prices have peaked out, but...
|
|
24 Jan 2022
|
Jyothy Labs
|
ICICI Securities Limited
|
322.50
|
150.00
|
137.40
(134.72%)
|
Target met |
Hold
|
|
|
Price hike insufficient to curb margin decline whiteners, detergents, dishwashing products, household insecticides (HI) & personal care products. The company has a leading brand Ujala in fabric whitener with 84.5% market share. It has a sizable dish washing & HI business with mid-teens market...
|
|
23 Jan 2022
|
Jyothy Labs
|
Motilal Oswal
|
322.50
|
150.00
|
137.40
(134.72%)
|
Target met |
Neutral
|
|
|
Sales came in above our estimate in 3QFY22. While gross margin was affected by steep material cost inflation, it was in line with our estimate. However, higher-than-anticipated ad spends led to a miss on operating margin. While input costs are expected to remain elevated, the benefits of price hikes would come into effect in 4QFY22 and should provide a sequentially better margin, notwithstanding sharp inflation further. Topline growth is key for a company with sales of just over INR20b. The likelihood of consistent 15% sales growth (essential for any re-rating)...
|
|
03 Nov 2021
|
Jyothy Labs
|
ICICI Securities Limited
|
322.50
|
170.00
|
155.45
(107.46%)
|
Target met |
Hold
|
|
|
whiteners, detergents, dishwashing products, household insecticides (HI) & personal care products. The company has leading brand Ujala in fabric whitener with 84.9% market share. It has a sizable dish washing & HI business with mid-teens market share. Large part of the revenue is generated from Kerala and Tamil Nadu. The company has 23 manufacturing facilities in India. Its pan-India distribution reach is close to 2.8 million outlets with direct reach of 0.86 million. Its major brands include Ujala & Henko in fabric wash, Exo & Pril, in dishwashing, Margo in soaps & Maxo in HI categories...
|
|
06 Aug 2021
|
Jyothy Labs
|
Geojit BNP Paribas
|
322.50
|
190.00
|
172.20
(87.28%)
|
|
Accumulate
|
|
|
For Q1FY22, revenue grew by 21%YoY backed by healthy growth across all categories owing to higher growth in General Trade (GT) and E-Com channels. Dishwashing grew by 22%, Personal care (13.5% YoY), and Household Insecticides-HI (13%YoY) on YoY basis. JLL's enhanced focus on essential hygiene products along with healthy rural demand aided volume growth. Fabric care segment grew by 27% YoY (Vs de-growth of 24% in YoY quarter) but is still to reach pre-covid levels due to work from home culture and closure of schools. Covid-19 have changed consumer preferences more towards essential & hygiene products. ~85% of the product portfolio comprises of...
|
|
19 May 2021
|
Jyothy Labs
|
ICICI Securities Limited
|
322.50
|
160.00
|
144.45
(123.26%)
|
Target met |
Hold
|
|
|
JLL is enhancing its rural distribution network by adding 500 sub-stockists in FY21. Moreover, it is also concentrating on increasing van coverage in rural India to drive penetration & frequency of consumption. In urban regions, it has increased its direct distribution reach to ~9 lakh retail outlets. Moreover, the company has also rationalised trade pipeline by 10 days after implementing continuous replenishment system (CRS). We believe distribution upgradation & expansion would drive growth in dishwashing category for the company. We estimate 9.3% revenue CAGR in FY21-23....
|
|
18 May 2021
|
Jyothy Labs
|
Motilal Oswal
|
322.50
|
150.00
|
144.45
(123.26%)
|
Target met |
Neutral
|
|
|
While there has been improvement in net WC days and the company is now net debt free, topline growth is key for a company with sales of only INR19b. The likelihood of 15% sales growth continues to appear difficult. Sales growth CAGR has been 3.7% in the preceding five years. With margin likely to under pressure due to material cost increase, earnings growth prospects remain weak. Maintain Neutral Double-digit volume growth, overall performance below our expectation...
|